GlassScriptPhysician profile
Arash Yousefi
NPI 1316477235
$3,633.14
in general payments reported to CMS, 2019-2025
11 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,120 · 2022: $786 · 2023: $287 · 2024: $154 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,144.69 | 2021-2022 | |
| Abbott Laboratories | $875.80 | 2021-2022 | |
| Medtronic, INC. | $583.55 | 2021 | |
| Relievant Medsystems, INC. | $396.84 | 2021-2023 | Intracept |
| Boston Scientific Corporation | $192.90 | 2021-2025 | General - Pain Management |
| Abbvie INC. | $122.63 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $120.17 | 2024 | Ajovy |
| Spinal Simplicity, LLC | $119.00 | 2023 | Ha Minuteman G3-R |
| Becton, Dickinson and Company | $42.79 | 2025 | Hemosphere |
| Vertex Pharmaceuticals Incorporated | $33.45 | 2024 | |
| Stimwave Technologies Incorporated | $1.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Yousefi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.